Table 2.
Titers | Patients with asthma (n = 95) | Control subjects (n = 99) | P value | |
n (%) | n (%) | |||
Anti-Hsp60 | 1:10 | 17 (17.9) | 5 (5.1) | 0.001 |
1:20 | 8 (8.4) | 1 (1.0) | 0.014 | |
1:40 | 5 (5.3) | 0 (0.0) | 0.027 | |
1:80 | 5 (5.3) | 0 (0.0) | 0.027 | |
Anti-Hsp70 | 1:10 | 32 (33.7) | 8 (8.1) | <0.001 |
1:20 | 19 (20.0) | 4 (4.0) | <0.001 | |
1:40 | 13 (13.7) | 1 (1.0) | <0.001 | |
1:80 | 9 (9.5) | 0 (0.0) | 0.001 | |
Anti-Hsps* | 1:10 | 37 (38.9) | 9 (9.1) | <0.001 |
* Combined positive rate of anti-Hsp60 and /or anti-Hsp70 for titers 1:10–1:80.